ACTR-51. REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR

Glioblastomas are highly aggressive, grade IV tumors of glial cells that arise either as de novo primary tumors or as secondary tumors, which malignantly transformed from lower grade gliomas. Secondary glioblastomas have a relatively low incidence making up 5–10% of all glioblastoma diagnoses and te...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Shu, Hui-Kuo, Gurbani, Saumya, Ramesh, Karthik, Weinberg, Brent, Voloschin, Alfredo, Olson, Jeffrey, Shim, Hyunsuk
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Adult Clinical Trials - Non-Immunologic
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846946/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.093
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items